Affimed N.V. (AFMDQ) vs GENPREX (GNPX)

Affimed N.V. and GENPREX are both Biotechnology companies. Affimed N.V. and GENPREX are of similar size ($2.8M and $2.8M). Affimed N.V. has negative trailing earnings, so its P/E is not meaningful; GENPREX trades at 0.0×. GENPREX has the higher net margin (0.00% vs −7,834.6%) and the higher return on invested capital (0.00% vs −13,558.8%). Across the 14 metrics below, GENPREX leads on 9 and Affimed N.V. on 5.

Valuation

Metric AFMDQ GNPX Biotechnology median
P/E n/m 0.05 7.88
P/S n/m n/m 11.47
P/B n/m 0.11 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.26 0.86 0.74
EV/Sales (19.16) n/m 10.73
Earnings yield 0.00% 2,033.43% (28.84%)
Free cash flow yield 0.00% (950.28%) (23.03%)

Profitability

Metric AFMDQ GNPX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (7,858.63%) 0.00% 0.00%
Net margin (7,834.59%) 0.00% 0.00%
Free cash flow margin (8,603.91%) 0.00% 0.00%
Return on equity (148.64%) (203.86%) (57.72%)
Return on assets (86.68%) (157.40%) (49.22%)
Return on invested capital (13,558.83%) 0.00% 0.00%

Growth

Metric AFMDQ GNPX Biotechnology median
Revenue growth (TTM) (95.23%) — 5.64%
EPS growth (last fiscal year) (21.75%) 93.48% —
Revenue growth, 5-year CAGR (22.67%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AFMDQ GNPX Biotechnology median
Debt to equity 0.47 0.00 0.00
Current ratio 1.93 6.76 4.73
Net debt to EBITDA 0.58 0.50 0.96

Dividend

Metric AFMDQ GNPX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric AFMDQ GNPX Biotechnology median
Market cap 2.76m 2.80m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack